0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Research Report 2026
Published Date: 2026-04-18
|
Report Code: QYRE-Auto-6P17247
Home | Market Reports
Global Alzheimer s Disease AD Blood based Detection Kits Market Research Report 2024
BUY CHAPTERS

Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Research Report 2026

Code: QYRE-Auto-6P17247
Report
2026-04-18
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Alzheimer's Disease (AD) Blood-based Detection Kits Market

The global Alzheimer's Disease (AD) Blood-based Detection Kits market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Alzheimer's Disease (AD) Blood-based Detection Kits competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Alzheimer's Disease (AD) blood-based detection kits are diagnostic tools designed to detect biomarkers associated with Alzheimer's disease in blood samples. These kits offer a non-invasive and potentially cost-effective method for early detection and monitoring of Alzheimer's disease. Several types of blood-based detection kits for Alzheimer's disease are being developed and studied, each targeting specific biomarkers or molecular signatures associated with the disease.
The North American market for Alzheimer's Disease (AD) Blood-based Detection Kits is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Alzheimer's Disease (AD) Blood-based Detection Kits is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Alzheimer's Disease (AD) Blood-based Detection Kits include Roche Diagnostics, Fujirebio, Quanterix, Revvity, People Bio, Easund Bio-tech and Pharmakea, MagQu, Solgent, Sysmex, Fujifilm, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Alzheimer's Disease (AD) Blood-based Detection Kits market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Alzheimer's Disease (AD) Blood-based Detection Kits. The Alzheimer's Disease (AD) Blood-based Detection Kits market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Alzheimer's Disease (AD) Blood-based Detection Kits market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Alzheimer's Disease (AD) Blood-based Detection Kits manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Alzheimer's Disease (AD) Blood-based Detection Kits Market Report

Report Metric Details
Report Name Alzheimer's Disease (AD) Blood-based Detection Kits Market
Segment by Type
  • Amyloid Beta (Aβ) Detection Kits
  • Tau Protein Detection Kits
  • Others
by Application
  • Medical
  • Research
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche Diagnostics, Fujirebio, Quanterix, Revvity, People Bio, Easund Bio-tech and Pharmakea, MagQu, Solgent, Sysmex, Fujifilm, Immuno-Biological Laboratories, Shenzhen Anqun Bioengineering, Amoneta Diagnostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Alzheimer's Disease (AD) Blood-based Detection Kits manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Alzheimer's Disease (AD) Blood-based Detection Kits sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Alzheimer's Disease (AD) Blood-based Detection Kits Market report?

Ans: The main players in the Alzheimer's Disease (AD) Blood-based Detection Kits Market are Roche Diagnostics, Fujirebio, Quanterix, Revvity, People Bio, Easund Bio-tech and Pharmakea, MagQu, Solgent, Sysmex, Fujifilm, Immuno-Biological Laboratories, Shenzhen Anqun Bioengineering, Amoneta Diagnostics

What are the Application segmentation covered in the Alzheimer's Disease (AD) Blood-based Detection Kits Market report?

Ans: The Applications covered in the Alzheimer's Disease (AD) Blood-based Detection Kits Market report are Medical, Research

What are the Type segmentation covered in the Alzheimer's Disease (AD) Blood-based Detection Kits Market report?

Ans: The Types covered in the Alzheimer's Disease (AD) Blood-based Detection Kits Market report are Amyloid Beta (Aβ) Detection Kits, Tau Protein Detection Kits, Others

1 Alzheimer's Disease (AD) Blood-based Detection Kits Market Overview
1.1 Product Definition
1.2 Alzheimer's Disease (AD) Blood-based Detection Kits by Type
1.2.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Value by Type: 2025 vs 2032
1.2.2 Amyloid Beta (Aβ) Detection Kits
1.2.3 Tau Protein Detection Kits
1.2.4 Others
1.3 Alzheimer's Disease (AD) Blood-based Detection Kits by Application
1.3.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Value by Application: 2025 vs 2032
1.3.2 Medical
1.3.3 Research
1.4 Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Size Estimates and Forecasts
1.4.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue 2021–2032
1.4.2 Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales 2021–2032
1.4.3 Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Alzheimer's Disease (AD) Blood-based Detection Kits Market Competition by Manufacturers
2.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Market Share by Manufacturers (2021–2026)
2.2 Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Alzheimer's Disease (AD) Blood-based Detection Kits Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Alzheimer's Disease (AD) Blood-based Detection Kits, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Alzheimer's Disease (AD) Blood-based Detection Kits, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Alzheimer's Disease (AD) Blood-based Detection Kits, Product Types and Applications
2.7 Global Key Manufacturers of Alzheimer's Disease (AD) Blood-based Detection Kits, Date of Entry into the Industry
2.8 Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Competitive Situation and Trends
2.8.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Alzheimer's Disease (AD) Blood-based Detection Kits Players Market Share by Revenue
2.8.3 Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Scenario by Region
3.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Region: 2021–2032
3.2.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Region: 2021–2026
3.2.2 Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Region: 2027–2032
3.3 Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Region: 2021–2032
3.3.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Region: 2021–2026
3.3.2 Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Region: 2027–2032
3.4 North America Alzheimer's Disease (AD) Blood-based Detection Kits Market Facts & Figures by Country
3.4.1 North America Alzheimer's Disease (AD) Blood-based Detection Kits Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Country (2021–2032)
3.4.3 North America Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Alzheimer's Disease (AD) Blood-based Detection Kits Market Facts & Figures by Country
3.5.1 Europe Alzheimer's Disease (AD) Blood-based Detection Kits Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Country (2021–2032)
3.5.3 Europe Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Market Facts & Figures by Region
3.6.1 Asia Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Region (2021–2032)
3.6.3 Asia Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Alzheimer's Disease (AD) Blood-based Detection Kits Market Facts & Figures by Country
3.7.1 Latin America Alzheimer's Disease (AD) Blood-based Detection Kits Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Country (2021–2032)
3.7.3 Latin America Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Alzheimer's Disease (AD) Blood-based Detection Kits Market Facts & Figures by Country
3.8.1 Middle East and Africa Alzheimer's Disease (AD) Blood-based Detection Kits Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Country (2021–2032)
3.8.3 Middle East and Africa Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Type (2021–2032)
4.1.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Type (2021–2026)
4.1.2 Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Type (2027–2032)
4.1.3 Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Market Share by Type (2021–2032)
4.2 Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Type (2021–2032)
4.2.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Type (2021–2026)
4.2.2 Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Type (2027–2032)
4.2.3 Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Market Share by Type (2021–2032)
4.3 Global Alzheimer's Disease (AD) Blood-based Detection Kits Price by Type (2021–2032)
5 Segment by Application
5.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Application (2021–2032)
5.1.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Application (2021–2026)
5.1.2 Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Application (2027–2032)
5.1.3 Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Market Share by Application (2021–2032)
5.2 Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Application (2021–2032)
5.2.1 Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Application (2021–2026)
5.2.2 Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Application (2027–2032)
5.2.3 Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Market Share by Application (2021–2032)
5.3 Global Alzheimer's Disease (AD) Blood-based Detection Kits Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Roche Diagnostics
6.1.1 Roche Diagnostics Company Information
6.1.2 Roche Diagnostics Description and Business Overview
6.1.3 Roche Diagnostics Alzheimer's Disease (AD) Blood-based Detection Kits Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Roche Diagnostics Alzheimer's Disease (AD) Blood-based Detection Kits Product Portfolio
6.1.5 Roche Diagnostics Recent Developments/Updates
6.2 Fujirebio
6.2.1 Fujirebio Company Information
6.2.2 Fujirebio Description and Business Overview
6.2.3 Fujirebio Alzheimer's Disease (AD) Blood-based Detection Kits Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Fujirebio Alzheimer's Disease (AD) Blood-based Detection Kits Product Portfolio
6.2.5 Fujirebio Recent Developments/Updates
6.3 Quanterix
6.3.1 Quanterix Company Information
6.3.2 Quanterix Description and Business Overview
6.3.3 Quanterix Alzheimer's Disease (AD) Blood-based Detection Kits Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Quanterix Alzheimer's Disease (AD) Blood-based Detection Kits Product Portfolio
6.3.5 Quanterix Recent Developments/Updates
6.4 Revvity
6.4.1 Revvity Company Information
6.4.2 Revvity Description and Business Overview
6.4.3 Revvity Alzheimer's Disease (AD) Blood-based Detection Kits Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Revvity Alzheimer's Disease (AD) Blood-based Detection Kits Product Portfolio
6.4.5 Revvity Recent Developments/Updates
6.5 People Bio
6.5.1 People Bio Company Information
6.5.2 People Bio Description and Business Overview
6.5.3 People Bio Alzheimer's Disease (AD) Blood-based Detection Kits Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 People Bio Alzheimer's Disease (AD) Blood-based Detection Kits Product Portfolio
6.5.5 People Bio Recent Developments/Updates
6.6 Easund Bio-tech and Pharmakea
6.6.1 Easund Bio-tech and Pharmakea Company Information
6.6.2 Easund Bio-tech and Pharmakea Description and Business Overview
6.6.3 Easund Bio-tech and Pharmakea Alzheimer's Disease (AD) Blood-based Detection Kits Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Easund Bio-tech and Pharmakea Alzheimer's Disease (AD) Blood-based Detection Kits Product Portfolio
6.6.5 Easund Bio-tech and Pharmakea Recent Developments/Updates
6.7 MagQu
6.7.1 MagQu Company Information
6.7.2 MagQu Description and Business Overview
6.7.3 MagQu Alzheimer's Disease (AD) Blood-based Detection Kits Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 MagQu Alzheimer's Disease (AD) Blood-based Detection Kits Product Portfolio
6.7.5 MagQu Recent Developments/Updates
6.8 Solgent
6.8.1 Solgent Company Information
6.8.2 Solgent Description and Business Overview
6.8.3 Solgent Alzheimer's Disease (AD) Blood-based Detection Kits Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Solgent Alzheimer's Disease (AD) Blood-based Detection Kits Product Portfolio
6.8.5 Solgent Recent Developments/Updates
6.9 Sysmex
6.9.1 Sysmex Company Information
6.9.2 Sysmex Description and Business Overview
6.9.3 Sysmex Alzheimer's Disease (AD) Blood-based Detection Kits Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Sysmex Alzheimer's Disease (AD) Blood-based Detection Kits Product Portfolio
6.9.5 Sysmex Recent Developments/Updates
6.10 Fujifilm
6.10.1 Fujifilm Company Information
6.10.2 Fujifilm Description and Business Overview
6.10.3 Fujifilm Alzheimer's Disease (AD) Blood-based Detection Kits Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Fujifilm Alzheimer's Disease (AD) Blood-based Detection Kits Product Portfolio
6.10.5 Fujifilm Recent Developments/Updates
6.11 Immuno-Biological Laboratories
6.11.1 Immuno-Biological Laboratories Company Information
6.11.2 Immuno-Biological Laboratories Description and Business Overview
6.11.3 Immuno-Biological Laboratories Alzheimer's Disease (AD) Blood-based Detection Kits Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Immuno-Biological Laboratories Alzheimer's Disease (AD) Blood-based Detection Kits Product Portfolio
6.11.5 Immuno-Biological Laboratories Recent Developments/Updates
6.12 Shenzhen Anqun Bioengineering
6.12.1 Shenzhen Anqun Bioengineering Company Information
6.12.2 Shenzhen Anqun Bioengineering Description and Business Overview
6.12.3 Shenzhen Anqun Bioengineering Alzheimer's Disease (AD) Blood-based Detection Kits Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Shenzhen Anqun Bioengineering Alzheimer's Disease (AD) Blood-based Detection Kits Product Portfolio
6.12.5 Shenzhen Anqun Bioengineering Recent Developments/Updates
6.13 Amoneta Diagnostics
6.13.1 Amoneta Diagnostics Company Information
6.13.2 Amoneta Diagnostics Description and Business Overview
6.13.3 Amoneta Diagnostics Alzheimer's Disease (AD) Blood-based Detection Kits Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Amoneta Diagnostics Alzheimer's Disease (AD) Blood-based Detection Kits Product Portfolio
6.13.5 Amoneta Diagnostics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alzheimer's Disease (AD) Blood-based Detection Kits Industry Chain Analysis
7.2 Alzheimer's Disease (AD) Blood-based Detection Kits Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alzheimer's Disease (AD) Blood-based Detection Kits Production Mode & Process Analysis
7.4 Alzheimer's Disease (AD) Blood-based Detection Kits Sales and Marketing
7.4.1 Alzheimer's Disease (AD) Blood-based Detection Kits Sales Channels
7.4.2 Alzheimer's Disease (AD) Blood-based Detection Kits Distributors
7.5 Alzheimer's Disease (AD) Blood-based Detection Kits Customer Analysis
8 Alzheimer's Disease (AD) Blood-based Detection Kits Market Dynamics
8.1 Alzheimer's Disease (AD) Blood-based Detection Kits Industry Trends
8.2 Alzheimer's Disease (AD) Blood-based Detection Kits Market Drivers
8.3 Alzheimer's Disease (AD) Blood-based Detection Kits Market Challenges
8.4 Alzheimer's Disease (AD) Blood-based Detection Kits Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Alzheimer's Disease (AD) Blood-based Detection Kits Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Alzheimer's Disease (AD) Blood-based Detection Kits, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Alzheimer's Disease (AD) Blood-based Detection Kits, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Alzheimer's Disease (AD) Blood-based Detection Kits, Product Types and Applications
 Table 12. Global Key Manufacturers of Alzheimer's Disease (AD) Blood-based Detection Kits, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Alzheimer's Disease (AD) Blood-based Detection Kits Companies by Tier (Tier 1, Tier 2, Tier 3), based on Alzheimer's Disease (AD) Blood-based Detection Kits Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Region (K Units), 2021–2026
 Table 18. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Market Share by Region (2021–2026)
 Table 19. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Region (K Units), 2027–2032
 Table 20. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Market Share by Region (2027–2032)
 Table 21. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Market Share by Region (2021–2026)
 Table 23. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Market Share by Region (2027–2032)
 Table 25. North America Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Country (K Units), 2021–2026
 Table 27. North America Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Country (K Units), 2027–2032
 Table 28. North America Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Country (K Units), 2021–2026
 Table 32. Europe Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Country (K Units), 2027–2032
 Table 33. Europe Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Country (K Units), 2021–2026
 Table 42. Latin America Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Country (K Units), 2027–2032
 Table 43. Latin America Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Alzheimer's Disease (AD) Blood-based Detection Kits Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Alzheimer's Disease (AD) Blood-based Detection Kits Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units) by Type (2021–2026)
 Table 51. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units) by Type (2027–2032)
 Table 52. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Market Share by Type (2021–2026)
 Table 53. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Market Share by Type (2027–2032)
 Table 54. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Market Share by Type (2021–2026)
 Table 57. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Market Share by Type (2027–2032)
 Table 58. Global Alzheimer's Disease (AD) Blood-based Detection Kits Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Alzheimer's Disease (AD) Blood-based Detection Kits Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units) by Application (2021–2026)
 Table 61. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units) by Application (2027–2032)
 Table 62. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Market Share by Application (2021–2026)
 Table 63. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales Market Share by Application (2027–2032)
 Table 64. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Market Share by Application (2021–2026)
 Table 67. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Market Share by Application (2027–2032)
 Table 68. Global Alzheimer's Disease (AD) Blood-based Detection Kits Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Alzheimer's Disease (AD) Blood-based Detection Kits Price (US$/Unit) by Application (2027–2032)
 Table 70. Roche Diagnostics Company Information
 Table 71. Roche Diagnostics Description and Business Overview
 Table 72. Roche Diagnostics Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Roche Diagnostics Alzheimer's Disease (AD) Blood-based Detection Kits Product
 Table 74. Roche Diagnostics Recent Developments/Updates
 Table 75. Fujirebio Company Information
 Table 76. Fujirebio Description and Business Overview
 Table 77. Fujirebio Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Fujirebio Alzheimer's Disease (AD) Blood-based Detection Kits Product
 Table 79. Fujirebio Recent Developments/Updates
 Table 80. Quanterix Company Information
 Table 81. Quanterix Description and Business Overview
 Table 82. Quanterix Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Quanterix Alzheimer's Disease (AD) Blood-based Detection Kits Product
 Table 84. Quanterix Recent Developments/Updates
 Table 85. Revvity Company Information
 Table 86. Revvity Description and Business Overview
 Table 87. Revvity Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Revvity Alzheimer's Disease (AD) Blood-based Detection Kits Product
 Table 89. Revvity Recent Developments/Updates
 Table 90. People Bio Company Information
 Table 91. People Bio Description and Business Overview
 Table 92. People Bio Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. People Bio Alzheimer's Disease (AD) Blood-based Detection Kits Product
 Table 94. People Bio Recent Developments/Updates
 Table 95. Easund Bio-tech and Pharmakea Company Information
 Table 96. Easund Bio-tech and Pharmakea Description and Business Overview
 Table 97. Easund Bio-tech and Pharmakea Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Easund Bio-tech and Pharmakea Alzheimer's Disease (AD) Blood-based Detection Kits Product
 Table 99. Easund Bio-tech and Pharmakea Recent Developments/Updates
 Table 100. MagQu Company Information
 Table 101. MagQu Description and Business Overview
 Table 102. MagQu Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. MagQu Alzheimer's Disease (AD) Blood-based Detection Kits Product
 Table 104. MagQu Recent Developments/Updates
 Table 105. Solgent Company Information
 Table 106. Solgent Description and Business Overview
 Table 107. Solgent Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Solgent Alzheimer's Disease (AD) Blood-based Detection Kits Product
 Table 109. Solgent Recent Developments/Updates
 Table 110. Sysmex Company Information
 Table 111. Sysmex Description and Business Overview
 Table 112. Sysmex Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Sysmex Alzheimer's Disease (AD) Blood-based Detection Kits Product
 Table 114. Sysmex Recent Developments/Updates
 Table 115. Fujifilm Company Information
 Table 116. Fujifilm Description and Business Overview
 Table 117. Fujifilm Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Fujifilm Alzheimer's Disease (AD) Blood-based Detection Kits Product
 Table 119. Fujifilm Recent Developments/Updates
 Table 120. Immuno-Biological Laboratories Company Information
 Table 121. Immuno-Biological Laboratories Description and Business Overview
 Table 122. Immuno-Biological Laboratories Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Immuno-Biological Laboratories Alzheimer's Disease (AD) Blood-based Detection Kits Product
 Table 124. Immuno-Biological Laboratories Recent Developments/Updates
 Table 125. Shenzhen Anqun Bioengineering Company Information
 Table 126. Shenzhen Anqun Bioengineering Description and Business Overview
 Table 127. Shenzhen Anqun Bioengineering Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Shenzhen Anqun Bioengineering Alzheimer's Disease (AD) Blood-based Detection Kits Product
 Table 129. Shenzhen Anqun Bioengineering Recent Developments/Updates
 Table 130. Amoneta Diagnostics Company Information
 Table 131. Amoneta Diagnostics Description and Business Overview
 Table 132. Amoneta Diagnostics Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Amoneta Diagnostics Alzheimer's Disease (AD) Blood-based Detection Kits Product
 Table 134. Amoneta Diagnostics Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Alzheimer's Disease (AD) Blood-based Detection Kits Distributors List
 Table 138. Alzheimer's Disease (AD) Blood-based Detection Kits Customers List
 Table 139. Alzheimer's Disease (AD) Blood-based Detection Kits Market Trends
 Table 140. Alzheimer's Disease (AD) Blood-based Detection Kits Market Drivers
 Table 141. Alzheimer's Disease (AD) Blood-based Detection Kits Market Challenges
 Table 142. Alzheimer's Disease (AD) Blood-based Detection Kits Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Alzheimer's Disease (AD) Blood-based Detection Kits
 Figure 2. Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Share by Type: 2025 & 2032
 Figure 4. Amyloid Beta (Aβ) Detection Kits Product Picture
 Figure 5. Tau Protein Detection Kits Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Share by Application: 2025 & 2032
 Figure 9. Medical
 Figure 10. Research
 Figure 11. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Size (US$ Million), 2021–2032
 Figure 13. Global Alzheimer's Disease (AD) Blood-based Detection Kits Sales (K Units), 2021–2032
 Figure 14. Global Alzheimer's Disease (AD) Blood-based Detection Kits Average Price (US$/Unit), 2021–2032
 Figure 15. Alzheimer's Disease (AD) Blood-based Detection Kits Report Years Considered
 Figure 16. Alzheimer's Disease (AD) Blood-based Detection Kits Sales Share by Manufacturers in 2025
 Figure 17. Global Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Alzheimer's Disease (AD) Blood-based Detection Kits Players: Market Share by Revenue in Alzheimer's Disease (AD) Blood-based Detection Kits in 2025
 Figure 19. Alzheimer's Disease (AD) Blood-based Detection Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Alzheimer's Disease (AD) Blood-based Detection Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Alzheimer's Disease (AD) Blood-based Detection Kits Sales Market Share by Country (2021–2032)
 Figure 22. North America Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Market Share by Country (2021–2032)
 Figure 23. United States Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Alzheimer's Disease (AD) Blood-based Detection Kits Sales Market Share by Country (2021–2032)
 Figure 26. Europe Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Market Share by Region (2021–2032)
 Figure 34. China Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Alzheimer's Disease (AD) Blood-based Detection Kits Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Alzheimer's Disease (AD) Blood-based Detection Kits Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Alzheimer's Disease (AD) Blood-based Detection Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Alzheimer's Disease (AD) Blood-based Detection Kits by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Alzheimer's Disease (AD) Blood-based Detection Kits by Type (2021–2032)
 Figure 54. Global Alzheimer's Disease (AD) Blood-based Detection Kits Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Alzheimer's Disease (AD) Blood-based Detection Kits by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Alzheimer's Disease (AD) Blood-based Detection Kits by Application (2021–2032)
 Figure 57. Global Alzheimer's Disease (AD) Blood-based Detection Kits Price (US$/Unit) by Application (2021–2032)
 Figure 58. Alzheimer's Disease (AD) Blood-based Detection Kits Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS